Great Wall of China Trek 2026
Could you take on an adventure of a lifetime for Retina UK and take part in the Great Wall of China Trek in November 2026?
Search
Search results
Camino de Santiago Trek 2026
Could you take on an adventure of a lifetime for Retina UK and take part in the Camino de Santiago, across Spain in September 2026?
Jump In July 2026
Face your fears and support Retina UK with a charity skydive this summer!
Halloween Skydive 2026
Are you ready to sign up for a spooky skydive and face your fears for Retina UK?
Optogenetics
The BBC covered a story on Monday 24 May about optogenetics partially restoring the sight of a man living with retinitis pigmentosa in France.
Encouraging results from ProQR USH2A clinical trial
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.
Phase 3 clinical trial has been given approval by FDA
The FDA has given Ocugen permission to start their phase 3 gene therapy clinical trial for retinitis pigmentosa (RP).
Renewed Momentum for XLRP: MeiraGTx Targets Rapid Approval Path for bota-vec following reacquisition from Johnson and Johnson
It has recently been announced that Meira-GTx, who originally developed bota-vec and collaborated with J&J during its early clinical trials, have entered into an asset purchase agreement with J&J to acquire bota-vec and progress the program towards global regulatory filings for approval.
South Wales Local Peer Support Group
Tuesday 12 May 2026, 7.00pm - 8.00pm - via Zoom - Please come and join facilitator Stuart Francis and our new South Wales Peer Support Group where we are delighted to welcome guest speaker Becs Harris, Wellbeing Service Manager at Sight Cymru.
Stem cells
Stem cells are a special type of cell, which under the right conditions can be encouraged to grow into any other type of cell in the body, including retinal cells (rods, cones and retinal pigment epithelial cells).